Antiemetic & CIPN Guideline Updates
Jul 23, 2020•15 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
We summarize the changes to ASCO's latest Antiemetic Guidelines update as well as their guidelines for chemotherapy-induced peripheral neuropathy (CIPN).
Then, we take a look at the PO decitabine approval and ponder the question, does low albumin decrease tolerability to some TKIs?
For the best experience, listen in Metacast app for iOS or Android